Precipio, Inc.
PRPONasdaqHealthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $24.2M | $18.6M | $15.4M | $9.8M | $8.7M | $7.4M |
| Operating income | −$1.2M | −$4.2M | −$7.6M | −$12.8M | −$9.6M | −$9.1M |
| Net income | −$363,000 | −$4.3M | −$5.9M | −$12.2M | −$8.5M | −$10.6M |
| Total assets | $21.3M | $17.0M | $18.1M | $21.5M | $30.4M | $20.7M |
| Total liabilities | $6.8M | $4.9M | $3.7M | $5.1M | $5.8M | $6.6M |
| Equity | $14.6M | $12.1M | $14.4M | $16.3M | $24.6M | $14.1M |
| EPS (diluted) | $-0.23 | $-2.93 | $-4.51 | $-10.73 | $-0.40 | $-0.85 |
| Shares out. | 1.5M | 1.4M | 23.4M | 22.7M | 18.1M | 8.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −5.0%
- Net margin
- −1.5%
- Return on equity
- −2.5%
- Return on assets
- −1.7%
- Return on capital (ROCE)
- −6.8%
- Liabilities / assets
- 31.7%
- Debt / equity
- 0.46×
- Book value / share
- $9.68
- Revenue growth (YoY)
- 30.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -13.13distress
- Accruals / assets
- −4.9%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 4 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2018
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2018
- NT 10-Qmissed a reporting deadline ↗May 15, 2018
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Leviticus Partners LpPassive (13G)Feb 10, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 14,627 | 1.0 | +106.7% |
| Apr 30, 2026 | 7,078 | 1.0 | -22.1% |
| Apr 15, 2026 | 9,087 | 1.0 | +49.8% |
| Mar 31, 2026 | 6,065 | 1.0 | -1.0% |
| Mar 13, 2026 | 6,126 | 1.0 | +70.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 6, 2026
- Results of operationsFeb 27, 2026
- Director / officer changeDec 29, 2025
- Regulation FD disclosureNov 6, 2025
- Terminated a material agreementSep 3, 2025
- Regulation FD disclosureAug 18, 2025
- Regulation FD disclosureJul 31, 2025
- Shareholder voteJun 17, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTMay 26, 2026
- 4OWNERSHIP DOCUMENTMay 21, 2026
- 144May 19, 2026
- 10-QMay 14, 2026
- 8-KFORM 8-KMay 6, 2026
- ARSApr 28, 2026
- DEFA14AApr 28, 2026
- DEF 14AApr 28, 2026
- 4OWNERSHIP DOCUMENTApr 17, 2026
- 4OWNERSHIP DOCUMENTApr 17, 2026
- 4OWNERSHIP DOCUMENTApr 17, 2026
- 4OWNERSHIP DOCUMENTApr 10, 2026
- 10-KMar 30, 2026
- 8-KFORM 8-KFeb 27, 2026
- SCHEDULE 13G/AFeb 10, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.